首页 | 本学科首页   官方微博 | 高级检索  
   检索      


Structure-function relationships and molecular genetics of the 3β-hydroxysteroid dehydrogenase gene family
Authors:Jacques Simard  Rocio Sanchez  Francine Durocher  Eric Rhaume  Carl Turgeon  Yvan Labrie  Van Luu-The  Farida Mebarki  Yves Morel  Yvan de Launoit  Fernand Labrie
Institution:

1 Medical Research Council Group in Molecular Endocrinology, CHUL Research Center and Laval University, Québec, Canada

2 INSERM U329 and Department of Pediatrics, Université de Lyon and Hôpital Debrousse, Lyon Cedex 05, France

3 CNRS U1160 and Unité d'Oncologie Moléculaire, Institut Pasteur, Lille, France

Abstract:The isoenzymes of the 3β-hydroxysteroid dehydrogenase/5-ene-4-ene-isomerase (3β-HSD) gene family catalyse the transformation of all 5-ene-3β-hydroxysteroids into the corresponding 4-ene-3-keto-steroids and are responsible for the interconversion of 3β-hydroxy- and 3-keto-5greek small letter alpha-androstane steroids. The two human 3β-HSD genes and the three related pseudogenes are located on the chromosome 1p13.1 region, close to the centromeric marker D1Z5. The 3β-HSD isoenzymes prefer NAD+ to NADP+ as cofactor with the exception of the rat liver type III and mouse kidney type IV, which both prefer NADPH as cofactor for their specific 3-ketosteroid reductase activity due to the presence of Tyr36 in the rat type III and of Phe36 in mouse type IV enzymes instead of Asp36 found in other 3β-HSD isoenzymes. The rat types I and IV, bovine and guinea pig 3β-HSD proteins possess an intrinsic 17β-HSD activity psecific to 5greek small letter alpha-androstane 17β-ol steroids, thus suggesting that such “secondary” activity is specifically responsible for controlling the bioavailability of the active androgen DHT. To elucidate the molecular basis of classical form of 3β-HSD deficiency, the structures of the types I and II 3β-HSD genes in 12 male pseudohermaphrodite 3β-HSD deficient patients as well as in four female patients were analyzed. The 14 different point mutations characterized were all detected in the type II 3β-HSD gene, which is the gene predominantly expressed in the adrenals and gonads, while no mutation was detected in the type I 3β-HSD gene predominantly expressed in the placenta and peripheral tissues. The mutant type II 3β-HSD enzymes carrying mutations detected in patients affected by the salt-losing form exhibit no detectable activity in intact transfected cells, at the exception of L108W and P186L proteins, which have some residual activity (not, vert, similar1%). Mutations found in nonsalt-loser patients have some residual activity ranging from not, vert, similar1 to not, vert, similar10% compared to the wild-type enzyme. Characterization of mutant proteins provides unique information on the structure-function relationships of the 3β-HSD superfamily.
Keywords:
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号